Sort
130,381 grants matching “hiv”
Rectal health, behaviors and product acceptability
$1,144,895Pamina Mae Gorbach · University Of California Los Angeles · U19 · FY2008 · AI
Integrating Addiction and Infectious Diseases Services into Primary Care in Rural Settings
$1,144,825Frederick Lewis Altice · Yale University · R01 · FY2025 · DA
Clinical Trials Network Mid-Atlantic Collaborative Group
$1,144,797Maxine L Stitzer · Johns Hopkins University · U10 · FY2015 · DA
PATHOGENESIS OF HIV-ASSOCIATED NEPHROPATHY
$1,144,747Mount Sinai School Of Medicine Of Nyu · P01 · FY2002 · DK
Production of Pedigreed SPF Rhesus Macaques
$1,144,683Jeffrey A Roberts · University Of California At Davis · U42 · FY2023 · OD
The National Drug Abuse Treatment Clinical Trials Network
$1,144,584Roger D. Weiss · Mclean Hospital · UG1 · FY2019 · DA
Ultrasensitive Single-Genome Sequencing to Study HIV Transmission and Evolution
$1,144,522Mary Kearney · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
ZCM: A novel broad-spectrum microbicide for STIs
$1,144,510Melissa J Robbiani · Population Council · U19 · FY2006 · AI
Targeted CRISPR/Cas Editing to Eliminate SIV CNS Reservoir in Methamphetamine-Exposed Rhesus Macaques on ART
$1,144,344Binhua Ling · Texas Biomedical Research Institute · R01 · FY2025 · DA
Integrating HCV services into HIV programs for PWID in India
$1,144,204Shruti H Mehta · Johns Hopkins University · R01 · FY2021 · AI
HIV-1 Reverse Transcriptase
$1,144,087Stephen H Hughes · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Expanding and Increasing Access to HIV and AIDS Treatment and Care
$1,144,036Benjamin Schwartz · Care Usa · U2G · FY2011 · PS
Tfh and B cells in HIV/SIV pathogenesis and vaccination
$1,143,986Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Tfh and B cells in HIV/SIV pathogenesis and vaccination
$1,143,986Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
PRESCIENT: A phase IIc, open-label, randomized controlled trial of ultra-short course bedaquiline, clofazimine, pyrazinamide and delamanid versus standard therapy for drug-susceptible tuberculosis
$1,143,959Serena Patricia Koenig · Brigham And Women'S Hospital · U01 · FY2024 · AI
Scanning Electron Microscope with 3View
$1,143,907Fengxia Liang · New York University School Of Medicine · S10 · FY2016 · OD
Sputum Transcriptomic Expression Profiling in Study 31: Express 31
$1,143,898Payam Nahid · University Of California, San Francisco · R01 · FY2017 · AI
J-RISE: Relevant Implementation Strategies to Eliminate the social and structural barriers to HIV services among Justice-involved Black men who have sex with men
$1,143,836Russell Brewer · University Of Chicago · R01 · FY2024 · MH
Western States Node of the National Drug Abuse Treatment Clinical Trials Network
$1,143,747James L. Sorensen · University Of California, San Francisco · U10 · FY2010 · DA
Design Of Immunogens
$1,143,723Peter D Kwong · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
TRIAD-2 Center for Health Disparities Research
$1,143,709Debra C Wallace · University Of North Carolina Greensboro · P20 · FY2013 · MD
East Africa IEDEA Regional Consortium
$1,143,702Constantin T Yiannoutsos · Indiana Univ-Purdue Univ At Indianapolis · U01 · FY2007 · AI
Characterize HIV-Infected T-Cell Clones on ART and Impact of Experimental Interventions
$1,143,693Mary Kearney · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Protein-mediated membrane remodeling
$1,143,528Leonid V. Chernomordik · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2010 · HD
Chlamydial Immunity and Vaccine Development
$1,143,479Harlan D Caldwell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI